Boronic acid based inhibitors of autotaxin: Understanding their biological role in terms of quantitative structure activity relationships (QSAR)

Letters in Drug Design and Discovery

Volumn 10, Issue 1, 2013, Pages 11-18

  Katsamakas, Sotirios ^a   Hadjipavlou Litina, Dimitra ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Boronic Acid based Autotaxin Inhibitors; Hydrophobicity; Molar Refractivity; QSAR

Indexed keywords

AUTOTAXIN; BORONIC ACID DERIVATIVE; HA 155; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE; PHOSPHODIESTERASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; DIABETES MELLITUS; DRUG DESIGN; ENZYME ACTIVITY; INFLAMMATION; OBESITY; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; TUMOR GROWTH;

EID: 84875420342     PISSN: 15701808     EISSN: 1875628X     Source Type: Journal    
DOI: 10.2174/157018013804142483     Document Type: Article

References (44)

1. (a) Ferry, G.; Tellier, E.; Try, A.; Grés, S.; Naime, I.; Simon, M. F.; Rodriguez, M.; Boucher, J.; Tack, I.; Gesta, S.; Chomarat, P.; Dieu, M.; Raes, M.; Galizzi, J. P.; Valet, P.; Boutin, J. A.; Saulnier- Blache, J. S., Autotaxin Is Released from Adipocytes, Catalyzes Lysophosphatidic Acid Synthesis, and Activates Preadipocyte Proliferation. Journal of Biological Chemistry 2003, 278(20), 18162-18169;
2. (b) Gesta, S.; Simon, M.-F.; Rey, A.; Sibrac, D.; Girard, A.; Lafontan, M.; Valet, P.; Saulnier-Blache, J. S., Secretion of a lysophospholipase D activity by adipocytes. Journal of Lipid Research 2002, 43(6), 904-910;
3. (c) Tokumura, A.; Majima, E.; Kariya, Y.; Tominaga, K.; Kogure, K.; Yasuda, K.; Fukuzawa, K., Identification of Human Plasma Lysophospholipase D, a Lysophosphatidic Acid-producing Enzyme, as Autotaxin, a Multifunctional Phosphodiesterase. Journal of Biological Chemistry 2002, 277(42), 39436-39442;
4. (d) Umezu-Goto, M.; Kishi, Y.; Taira, A.; Hama, K.; Dohmae, N.; Takio, K.; Yamori, T.; Mills, G. B.; Inoue, K.; Aoki, J.; Arai, H., Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. The Journal of Cell Biology 2002, 158(2), 227-233.
5. (a) Mills, G. B.; Moolenaar, W. H., The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer 2003, 3 (8), 582-591;
6. (b) Tigyi, G., Physiological responses to lysophosphatidic acid and related glycero-phospholipids. Prostaglandins & Other Lipid Mediators 2001, 64(1-4), 47-62.
7. (a) Ishii, I.; Fukushima, N.; Ye, X.; Chun, J., LYSOPHOSPHOLIPID RECEPTORS: Signaling and Biology. Annual Review of Biochemistry 2004, 73 (1), 321-354;
8. (b) Valentine, W. J.; Fujiwara, Y.; Tsukahara, R.; Tigyi, G., Lysophospholipid signaling: Beyond the EDGs. Biochimica et Biophysica Acta (BBA) - General Subjects 2008, 1780 (3), 597-605.
9. Aoki, J.; Inoue, A.; Okudaira, S., Two pathways for lysophosphatidic acid production. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2008, 1781(9), 513-518.
10. (a) Luquain, C.; Sciorra, V. A.; Morris, A. J., Lysophosphatidic acid signaling: how a small lipid does big things. Trends in biochemical sciences 2003, 28(7), 377-383;
11. (b) van Meeteren, L. A.; Moolenaar, W. H., Regulation and biological activities of the autotaxin-LPA axis. Progress in Lipid Research 2007, 46(2), 145-160.
12. (a) Murph, M.; Tanaka, T.; Liu, S.; Mills, G. B., Of Spiders and Crabs: The Emergence of Lysophospholipids and Their Metabolic Pathways as Targets for Therapy in Cancer. Clinical Cancer Research 2006, 12(22), 6598-6602;
13. (b) Tanaka, M.; Okudaira, S.; Kishi, Y.; Ohkawa, R.; Iseki, S.; Ota, M.; Noji, S.; Yatomi, Y.; Aoki, J.; Arai, H., Autotaxin Stabilizes Blood Vessels and Is Required for Embryonic Vasculature by Producing Lysophosphatidic Acid. Journal of Biological Chemistry 2006, 281(35), 25822-25830;
14. (c) van Meeteren, L. A.; Ruurs, P.; Stortelers, C.; Bouwman, P.; van Rooijen, M. A.; Pradère, J. P.; Pettit, T. R.; Wakelam, M. J. O.; Saulnier-Blache, J. S.; Mummery, C. L.; Moolenaar, W. H.; Jonkers, J., Autotaxin, a Secreted Lysophospholipase D, Is Essential for Blood Vessel Formation during Development. Molecular and Cellular Biology 2006, 26(13), 5015-5022.
15. Boucher, M. C.; Nguyen, Q. T.; Angioi, K., Mass community screening for diabetic retinopathy using a nonmydriatic camera with telemedicine. Canadian Journal of Ophthalmology /Journal Canadien d'Ophtalmologie 2005, 40(6), 734-742.
16. (a) Baker, D. L.; Fujiwara, Y.; Pigg, K. R.; Tsukahara, R.; Kobayashi, S.; Murofushi, H.; Uchiyama, A.; Murakami- Murofushi, K.; Koh, E.; Bandle, R. W.; Byun, H.-S.; Bittman, R.; Fan, D.; Murph, M.; Mills, G. B.; Tigyi, G., Carba Analogs of Cyclic Phosphatidic Acid Are Selective Inhibitors of Autotaxin and Cancer Cell Invasion and Metastasis. Journal of Biological Chemistry 2006, 281(32), 22786-22793;
17. (b) Cui, P.; Tomsig, J. L.; McCalmont, W. F.; Lee, S.; Becker, C. J.; Lynch, K. R.; Macdonald, T. L., Synthesis and biological evaluation of phosphonate derivatives as autotaxin (ATX) inhibitors. Bioorganic & Medicinal Chemistry Letters 2007, 17(6), 1634-1640;
18. (c) Jiang, G.; Xu, Y.; Fujiwara, Y.; Tsukahara, T.; Tsukahara, R.; Gajewiak, J.; Tigyi, G.; Prestwich, G. D., α-Substituted Phosphonate Analogues of Lysophosphatidic Acid (LPA) Selectively Inhibit Production and Action of LPA. ChemMedChem 2007, 2(5), 679-690;
19. (d) Liu, X.-W.; Sok, D.-E.; Yook, H.-S.; Sohn, C.-B.; Chung, Y.-J.; Kim, M. R., Inhibition of Lysophospholipase D Activity by Unsaturated Lysophosphatidic Acids or Seed Extracts Containing 1-Linoleoyl and 1-Oleoyl Lysophosphatidic Acid. Journal of Agricultural and Food Chemistry 2007, 55(21), 8717-8722.
20. Prestwich, G. D.; Gajewiak, J.; Zhang, H.; Xu, X.; Yang, G.; Serban, M., Phosphatase-resistant analogues of lysophosphatidic acid: Agonists promote healing, antagonists and autotaxin inhibitors treat cancer. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2008, 1781(9), 588-594.
21. (a) Ferry, G.; Moulharat, N.; Pradère, J.-P.; Desos, P.; Try, A.; Genton, A.; Giganti, A.; Beucher-Gaudin, M.; Lonchampt, M.; Bertrand, M.; Saulnier-Blache, J.-S.; Tucker, G. C.; Cordi, A.; Boutin, J. A., S32826, A Nanomolar Inhibitor of Autotaxin: Discovery, Synthesis and Applications as a Pharmacological Tool. Journal of Pharmacology and Experimental Therapeutics 2008, 327(3), 809-819;
22. (b) Gajewiak, J.; Tsukahara, R.; Fujiwara, Y.; Tigyi, G.; Prestwich, G. D., Synthesis, Pharmacology, and Cell Biology of sn-2-Aminooxy Analogues of Lysophosphatidic Acid. Organic Letters 2008, 10(6), 1111-1114;
23. (c) van Meeteren, L. A.; Brinkmann, V.; Saulnier-Blache, J. S.; Lynch, K. R.; Moolenaar, W. H., Anticancer activity of FTY720: Phosphorylated FTY720 inhibits autotaxin, a metastasis-enhancing and angiogenic lysophospholipase D. Cancer letters 2008, 266(2), 203-208.
24. (a) Albers, H. M. H. G.; Hendrickx, L. J. D.; van Tol, R. J. P.; Hausmann, J.; Perrakis, A.; Ovaa, H., Structure-Based Design of Novel Boronic Acid-Based Inhibitors of Autotaxin. Journal of Medicinal Chemistry 2011, 54(13), 4619-4626;
25. (b) Albers, H. M. H. G.; van Meeteren, L. A.; Egan, D. A.; van Tilburg, E. W.; Moolenaar, W. H.; Ovaa, H., Discovery and Optimization of Boronic Acid Based Inhibitors of Autotaxin. Journal of Medicinal Chemistry 2010, 53(13), 4958-4967.
26. (a) Hansch, C., The physicochemical approach to drug design and discovery (QSAR). Drug Development Research 1981, 1 (4), 267-309;
27. (b) Hansch, C.; Maloney, P. P.; Fujita, T.; Muir, R. M., Correlation of Biological Activity of Phenoxyacetic Acids with Hammett Substituent Constants and Partition Coefficients. Nature 1962, 194(4824), 178-180;
28. (c) Hansch, C. L., A; Hoekman, D, Exploring QSAR. Fundamentals and Applications in Chemistry and Biology. American Chemical Society Washington, DC, 1995.
29. (a) BioByte Corporation, C-QSAR database, 201 W Fourth str., Suite # 204, Claremont, CA 91711-4707, USA;
30. (b) www.biobyte.com.
31. Hansch, C. L., A; Hoekman, D, Exploring QSAR: Hydrophobic, electronic, and steric constants. American Chemical Society: Washington, DC, 1995.
32. (a) Hadjipavlou-Litina, D.; Garg, R.; Hansch, C., Comparative Quantitative Structure-Activity Relationship Studies (QSAR) on Non-Benzodiazepine Compounds Binding to Benzodiazepine Receptor (BzR). Chemical Reviews 2004, 104(9), 3751-3794;
33. (b) Hadjipavlou-Litina, D.; Hansch, C., Quantitative Structure-Activity Relationships of the Benzodiazepines. A Review and Reevaluation. Chemical Reviews 1994, 94(6), 1483-1505;
34. (c) Katsori, A. M.; Hadjipavlou-Litina, D., Chalcones in cancer: understanding their role in terms of QSAR. Curr Med Chem 2009, 16 (9), 1062-81;
35. (d) Pontiki, E.; Hadjipavlou-Litina, D., Histone deacetylase inhibitors (HDACIs). Structure - activity relationships: history and new QSAR perspectives. Medicinal Research Reviews 2012, 32 (1), 1-165.
36. (a) D'Arcy, P.; Linder, S., Proteasome deubiquitinases as novel targets for cancer therapy. The International Journal of Biochemistry & Cell Biology 2012, 44(11), 1729-1738;
37. (b) Esseltine, D.-L.; Mulligan, G., An Historic Perspective of Proteasome Inhibition. Seminars in hematology 2012, 49(3), 196-206.
38. Verma, R. P.; Hansch, C., An approach toward the problem of outliers in QSAR. Bioorganic & Medicinal Chemistry 2005, 13(15), 4597-4621.
39. Cramer, R. D.; Bunce, J. D.; Patterson, D. E.; Frank, I. E., Crossvalidation, Bootstrapping, and Partial Least Squares Compared with Multiple Regression in Conventional QSAR Studies. Quantitative Structure-Activity Relationships 1988, 7 (1), 18-25.
40. (a) Hansch, C. L., A; Hoekman, D, Exploring QSAR: Fundamentals and applications in chemistry and biology. American Chemical Society: Washington, DC, 1995; p 78;
41. (b) Michaelidou, A. S.; Hadjipavlou-Litina, D., Nonsteroidal Anti- Inflammatory Drugs (NSAIDs): A Comparative QSAR Study. Chemical Reviews 2005, 105(9), 3235-3271;
42. (c) Verma, R. P., Anti-cancer activities of 1,4-naphthoquinones: a QSAR study. Anticancer Agents Med Chem 2006, 6(5), 489-99.
43. (a) Hansch, C.; Kurup, A., QSAR of Chemical Polarizability and Nerve Toxicity. 2. Journal of Chemical Information and Computer Sciences 2003, 43(5), 1647-1651;
44. (b) Verma, R. P.; Kurup, A.; Hansch, C., On the role of polarizability in QSAR. Bioorganic & Medicinal Chemistry 2005, 13(1), 237-255.